The serum activity of one of the two ADA isoforms (ADA2) has recently been associated to fibrosis development in NAFLD patients, possibly due to a shift in macrophage polarization towards profibrotic, type 2 macrophages (42). The gene discussed is ADA; the disease is metabolic dysfunction-associated steatotic liver disease.